Sutter Health
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1981-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sutterhealth.org
Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment
Phase 2
Completed
- Conditions
- Mild Cognitive Impairment
- Interventions
- Drug: NewGam 10% IVIGOther: Placebo
- First Posted Date
- 2011-02-23
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Sutter Health
- Target Recruit Count
- 52
- Registration Number
- NCT01300728
- Locations
- 🇺🇸
Sutter Neuroscience Medical Group, Sacramento, California, United States
© Copyright 2025. All Rights Reserved by MedPath